文献速递中毒与环境急症

减少海洛因死亡中带回家纳洛酮的挑战:澳大利亚维多利亚州致死性海洛因过量病例回顾

Challenges with take-home naloxone in reducing heroin mortality: a review of fatal heroin overdose cases in Victoria, Australia.
PubMed 文献 · Clin Toxicol (Phila) · 2018-11-17
一句话结论在维多利亚州235例致死性海洛因过量病例中,仅8%存在旁观者及时干预的潜在机会,提示仅有带回家纳洛酮项目可能仅能小幅降低死亡数。

该研究回顾了澳大利亚维多利亚州2012年1月1日至2013年12月31日期间所有致死性海洛因过量病例(n=235),通过验尸数据和紧急医疗服务信息关联,评估若纳洛酮在事发地点和时间可用,旁观者是否有机会干预以避免死亡。结果显示79%(n=186)的致死事件发生在私人住所,83%(n=192)的死者当时独自一人;仅17%(n=38)有他人在场或目击,其中一半的目击者处于显著受损、失能或睡眠状态;仅8%(n=19)的病例存在旁观者或目击者进行适当及时干预的潜在机会。作者认为,仅引入带回家纳洛酮项目在研究期间可能仅能非常有限地减少致死性海洛因过量病例数。

要点

  • 研究期间共235例致死性海洛因过量病例,79%(n=186)发生在私人住所,83%(n=192)死者当时独自一人。
  • 仅17%(n=38)的病例有他人在场或目击,其中一半的目击者处于显著受损、失能或睡眠状态。
  • 仅8%(n=19)的致死性海洛因过量病例存在旁观者或目击者进行适当及时干预的潜在机会。
  • 作者认为,仅引入带回家纳洛酮项目在研究期间可能仅能非常有限地减少致死性海洛因过量病例数。

适用人群与场景

  • 澳大利亚维多利亚州2012年1月1日至2013年12月31日期间所有致死性海洛因过量病例(n=235)。

研究设计与关键结果

  • 研究类型为对致死性海洛因过量病例的回顾性队列研究,共纳入235例,数据来自验尸数据和紧急医疗服务信息关联。
  • 79%(n=186)的致死性海洛因过量病例发生在私人住所,83%(n=192)的死者当时独自一人。
  • 仅17%(n=38)的病例有他人在场或目击,其中一半的目击者处于显著受损、失能或睡眠状态。
  • 仅8%(n=19)的致死性海洛因过量病例存在旁观者或目击者进行适当及时干预的潜在机会。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(基于验尸数据和紧急医疗服务信息关联)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,仅引入带回家纳洛酮项目在研究期间可能仅能非常有限地减少致死性海洛因过量病例数。
  • 研究显示大多数致死性海洛因过量病例缺乏监督或目击者以提供有意义且及时的干预。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: Take-home naloxone (THN) programs have been implemented in order to reduce the number of heroin-overdose deaths. Because of recent legislative changes in Australia, there is a provision for a greater distribution of naloxone in the community, however, the potential impact of these changes for reduced heroin mortality remains unclear. The aim of this study was to examine the characteristics of the entire cohort of fatal heroin overdose cases and assess whether there was an opportunity for bystander intervention had naloxone been available at the location and time of each of the fatal overdose events to potentially avert the fatal outcome in these cases.

METHODS: The circumstances related to the fatal overdose event for the cohort of heroin-overdose deaths in the state of Victoria, Australia between 1 January 2012 and 31 December 2013 were investigated. Coronial data were investigated for all cases and data linkage was performed to additionally investigate the Emergency Medical Services information about the circumstances of the fatal heroin overdose event for each of the decedents.

RESULTS AND DISCUSSION: There were 235 fatal heroin overdose cases identified over the study period. Data revealed that the majority of fatal heroin overdose cases occurred at a private residence (n = 186, 79%) and where the decedent was also alone at the time of the fatal overdose event (n = 192, 83%). There were only 38 cases (17%) where the decedent was with someone else or there was a witness to the overdose event, and in half of these cases the witness was significantly impaired, incapacitated or asleep at the time of the fatal heroin overdose. There were 19 fatal heroin overdose cases (8%) identified where there was the potential for appropriate and timely intervention by a bystander or witness.

CONCLUSION: This study demonstrated that THN introduction alone could have led to a very modest reduction in the number of fatal heroin overdose cases over the study period. A lack of supervision or a witness to provide meaningful and timely intervention was evident in most of the fatal heroin overdose cases.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Stam NC, Gerostamoulos D, Smith K, et al. Challenges with take-home naloxone in reducing heroin mortality: a review of fatal heroin overdose cases in Victoria, Australia. Clin Toxicol (Phila). 2018. PMID: 30451007. doi:10.1080/15563650.2018.1529319

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。